Skip to main content
Log in

Frailty and Humoral Immune Responses Following COVID-19 Vaccination among Patients Undergoing Hemodialysis

  • Original Research
  • Published:
The journal of nutrition, health & aging

Abstract

Background

Patients with end-stage kidney disease who are undergoing dialysis have reduced immune responses to COVID-19 vaccination. Frailty is extremely common among dialysis patients and may contribute to the impaired immunogenicity. This study aimed to determine the association between frailty and humoral immune responses following COVID-19 vaccination in hemodialysis patients.

Design, Setting, Participants

Adult hemodialysis patients without prior SARS-CoV-2 infection who received a priming dose of ChAdOx1 nCoV-19, an adenovirus-vectored vaccine, were assessed for eligibility. Participants were categorized as robust, pre-frail, or frail using the Fried frailty criteria. Humoral responses were assessed 28 days after vaccination by measuring titers of anti-spike IgG antibodies. The primary outcome was anti-spike antibody seroconversion, defined as antibody levels ≥50 AU/mL. Multivariable-adjusted logistic regression models were used to assess the association between frailty status and the primary outcome.

Results

A total of 206 participants (mean age 67 ± 13 years, 50% women) were included in the study, of whom 50 (24%) were characterized as frail, 86 (42%) were characterized as pre-frail, and 70 (34%) were characterized as robust. Anti-spike antibody levels were progressively lower with more advanced stages of frailty (P <0.001). Compared with robust patients, a significantly smaller proportion of pre-frail and frail patients developed anti-spike antibody seroconversion (87%, 66%, and 40%, respectively; P <0.001). Frailty was associated with the absence of humoral responses after adjustment for age, sex, body mass index, diabetes, coronary artery disease, serum albumin, and lymphocyte count (OR=0.25; 95% CI, 0.08–0.80).

Conclusions

Frailty is independently associated with impaired humoral responses following COVID-19 vaccination among hemodialysis patients. Strategies aimed at preventing or attenuating frailty in the dialysis population are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Francis A, Baigent C, Ikizler TA, Cockwell P, Jha V. The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action. Kidney Int 2021; 99: 791–793.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Coccia M. Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis. Environ Res 2022; 204:112314.

    Article  CAS  PubMed  Google Scholar 

  3. Van Praet J, Reynders M, De Bacquer D, Viaene L, Schoutteten MK, Caluwé R, Doubel P, Heylen L, De Bel AV, Van Vlem B, Steensels D, De Vriese AS. Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study. J Am Soc Nephrol 2021; 32: 3208–3220.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fried LP, Cohen AA, Xue QL, Walston J, Bandeen-Roche K, Varadhan R. The physical frailty syndrome as a transition from homeostatic symphony to cacophony. Nat Aging 2021; 1: 36–46.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ye L, Tang X, Zhang H, Ge S, Yin L, Zhou Y, Chang J. Prevalence and risk factors of pre-frailty and frailty in maintenance haemodialysis patients in China: A cross-sectional Study. J Adv Nurs 2023. Online ahead of print.

  6. Pansarasa O, Pistono C, Davin A, Bordoni M, Mimmi MC, Guaita A, Cereda C. Altered immune system in frailty: Genetics and diet may influence inflammation. Ageing Res Rev 2019; 54: 100935.

    Article  PubMed  Google Scholar 

  7. Vetrano DL, Triolo F, Maggi S, Malley R, Jackson TA, Poscia A, Bernabei R, Ferrucci L, Fratiglioni L. Fostering healthy aging: The interdependency of infections, immunity and frailty. Ageing Res Rev 2021; 69: 101351.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146–156.

    Article  CAS  PubMed  Google Scholar 

  9. Chen LJ, Chen CY, Lue BH, Tseng MY, Wu SC. Prevalence and associated factors of frailty among elderly people in Taiwan. Int J Gerontol 2014; 8: 114–119.

    Article  Google Scholar 

  10. Orme JG, Reis J, Herz EJ. Factorial and discriminant validity of the Center for Epidemiological Studies Depression (CES-D) scale. J Clin Psychol 1986; 42: 28–33.

    Article  CAS  PubMed  Google Scholar 

  11. Bryan A, Pepper G, Wener MH, Fink SL, Morishima C, Chaudhary A, Jerome KR, Mathias PC, Greninger AL. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. J Clin Microbiol 2020; 58: e00941–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. SARS-CoV-2 IgG II Quant Assay User Manual, Abbott Laboratories, Diagnostics Division, 2020.

  13. Chen CY, Liu KT, Shih SR, Ye JJ, Chen YT, Pan HC, Hsu HJ, Sun CY, Lee CC, Wu CY, Lai CC, Wu IW. Neutralization Assessments Reveal High Cardiothoracic Ratio and Old Age as Independent Predictors of Low Neutralizing Antibody Titers in Hemodialysis Patients Receiving a Single Dose of COVID-19 Vaccine. J Pers Med 2022; 12: 68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Huang CF, Jang TY, Wu PH, Kuo MC, Yeh ML, Wang CW, Liang PC, Wei YJ, Hsu PY, Huang CI, Hsieh MY, Lin YH, Hsiao HH, Hsu CM, Huang CT, Lee CY, Chen YH, Chen TC, Lin KD, Wang SH, Wang SF, Huang JF, Dai CY, Chuang WL, Yu ML. Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort. Virol J 2023; 20: 112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Piernas C, Patone M, Astbury NM, Gao M, Sheikh A, Khunti K, Shankar-Hari M, Dixon S, Coupland C, Aveyard P, Hippisley-Cox J, Jebb SA. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study. Lancet Diabetes Endocrinol 2022; 10: 571–580.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yao X, Hamilton RG, Weng NP, Xue QL, Bream JH, Li H, Tian J, Yeh SH, Resnick B, Xu X, Walston J, Fried LP, Leng SX. Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine 2011; 29: 5015–5021.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Andrew MK, Shinde V, Ye L, Hatchette T, Haguinet F, Dos Santos G, McHhaney JE, Ambrose A, Boivin G, Bowie W, Chit A, HSherif M, Green K, Halperin S, Ibarguchi B, Johnstone J, Katz K, Langley J, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McGeer A, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN). The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People. J Infect Dis 2017; 216: 405–414.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kolland M, Riedl R, Bachler B, Ribitsch W, Niedrist T, Meissl AM, Rosenkranz AR, Kirsch AH. Decreased response to the mRNA anti-SARS-CoV-2 vaccine in hepatitis B vaccine non-responders and frail patients treated with peritoneal dialysis. Nephrol Dial Transplant 2022; gfac031. Online ahead of print.

  19. Tang F, Hammel IS, Andrew MK, Ruiz JG. Frailty Reduces Vaccine Effectiveness Against SARS-CoV-2 Infection: A Test-Negative Case Control Study Using National VA Data. J Nutr Health Aging 2023; 27: 81–88.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Tang F, Hammel IS, Andrew MK, Ruiz JG. COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study. Lancet Healthy Longev 2022; 3: e589–e598.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Salmerón Ríos S, Mas Romero M, Cortés Zamora EB, Tabernero Sahuquillo MT, Romero Rizos L, Sánchez-Jurado PM, Sánchez-Nievas G, Señalada JJB, García Nogueras I, Estrella Cazalla JD, Andrés-Pretel F, Murillo Romero A, Lauschke VM, Stebbing J, Abizanda P. Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study. J Am Geriatr Soc 2021; 69: 1441–1447.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sato Y, Yanagita M. Immunology of the ageing kidney. Nat Rev Nephrol 2019; 15: 625–640.

    Article  PubMed  Google Scholar 

  23. Collerton J, Martin-Ruiz C, Davies K, Hilkens CM, Isaacs J, Kolenda C, Parker C, Dunn M, Catt M, Jagger C, von Zglinicki T, Kirkwood TB. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev 2012; 133: 456–466.

    Article  CAS  PubMed  Google Scholar 

  24. Hubbard RE, O’Mahony MS, Savva GM, Calver BL, Woodhouse KW. Inflammation and frailty measures in older people. J Cell Mol Med 2009; 13: 3103–3109.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kooman JP, Dekker MJ, Usvyat LA, Kotanko P, van der Sande FM, Schalkwijk CG, Shiels PG, Stenvinkel P. Inflammation and premature aging in advanced chronic kidney disease. Am J Physiol Renal Physiol 2017; 313: F938–F950.

    Article  PubMed  Google Scholar 

  26. McAdams-DeMarco MA, Tan J, Salter ML, Gross A, Meoni LA, Jaar BG, Kao WH, Parekh RS, Segev DL, Sozio SM. Frailty and Cognitive Function in Incident Hemodialysis Patients. Clin J Am Soc Nephrol 2015; 10: 2181–2189.

    Article  PubMed  PubMed Central  Google Scholar 

  27. van Loon IN, Goto NA, Boereboom FTJ, Bots ML, Verhaar MC, Hamaker ME. Frailty Screening Tools for Elderly Patients Incident to Dialysis. Clin J Am Soc Nephrol 2017; 12: 1480–1488.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hsu CM, Weiner DE, Aweh G, Miskulin DC, Manley HJ, Stewart C, Ladik V, Hosford J, Lacson EC, Johnson DS, Lacson E Jr. COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider. Am J Kidney Dis 2021; 77: 748–756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hendra H, Vajgel G, Antonelou M, Neradova A, Manson B, Clark SG, Kostakis ID, Caplin B, Salama AD. Identifying prognostic risk factors for poor outcome following COVID-19 disease among in-centre haemodialysis patients: role of inflammation and frailty. J Nephrol 2021; 34: 315–323.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gilbert PB, Donis RO, Koup RA, Fong Y, Plotkin SA, Follmann D. A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines. N Engl J Med 2022; 387: 2203–2206.

    Article  PubMed  Google Scholar 

  31. Danthu C, Hantz S, Dahlem A, Duval M, Ba B, Guibbert M, El Ouafi Z, Ponsard S, Berrahal I, Achard JM, Bocquentin F, Allot V, Rerolle JP, Alain S, Touré F. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients. J Am Soc Nephrol 2021; 32: 2153–2158.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ng TC, Cheng HY, Chang HH, Liu CC, Yang CC, Jian SW, Liu DP, Cohen T, Lin HH. Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan. JAMA Intern Med 2021; 181: 913–921.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors appreciate the assistance of the Biobank of Taipei Tzu Chi Hospital for the collection and processing of clinical specimens.

Funding

Funding Sources: This work is supported by grants from Research Projects MOST 111231443-303-009, MOST 111-2314-B-303-032, MOST 112-2314-B-303-014, and MOST 112-2314-B-303-009-MY3 from the National Science and Technology Council, Taiwan and Research Projects TCRD-TPE-109-RT-2, TCRD-TPE-111-03, TCRD-TPE-111-05, and TCMF-CP 111-02 from Taipei Tzu Chi Hospital, Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Szu-Chun Hung.

Ethics declarations

Ethical standards: This study was approved by the Institutional Review Board of Taipei Tzu Chi Hospital (IRB 10-XD-117).

Conflict of Interest: There are no conflicts of interest.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, TY., Hung, SC. Frailty and Humoral Immune Responses Following COVID-19 Vaccination among Patients Undergoing Hemodialysis. J Nutr Health Aging 27, 980–986 (2023). https://doi.org/10.1007/s12603-023-1994-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-023-1994-x

Key words

Navigation